Korean Drug Co., Ltd. (KOSDAQ:014570)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,395.00
-55.00 (-1.59%)
At close: May 29, 2026
Market Cap38.08B -27.7%
Revenue (ttm)62.76B -6.0%
Net Income6.91B +1,445.1%
EPSn/a
Shares Out 10.91M
PE Ratio5.51
Forward PEn/a
Dividend160.00 (4.71%)
Ex-Dividend DateDec 29, 2025
Volume11,900
Open3,425.00
Previous Close3,450.00
Day's Range3,340.00 - 3,470.00
52-Week Range3,340.00 - 5,170.00
Beta0.22
Analystsn/a
Price Targetn/a
Earnings DateMay 28, 2026

About Korean Drug

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 270
Stock Exchange KOSDAQ
Ticker Symbol 014570
Full Company Profile

Financial Performance

In 2025, Korean Drug's revenue was 62.51 billion, a decrease of -14.37% compared to the previous year's 73.00 billion. Earnings were 6.51 billion, an increase of 117.42%.

Financial Statements